Subscribe
Sign in
Share this post
Business San Diego
Kevin Lind, Biotech Serial CEO, Details Longboard Pharmaceuticals $2.6B M&A Deal — and What's Next
Copy link
Facebook
Email
Notes
More
Kevin Lind, Biotech Serial CEO, Details…
Fred Grier
Feb 5
6
Share this post
Business San Diego
Kevin Lind, Biotech Serial CEO, Details Longboard Pharmaceuticals $2.6B M&A Deal — and What's Next
Copy link
Facebook
Email
Notes
More
Longboard CEO Details Decision to Sell Publicly-Traded Rare Disease Company
Read →
Comments
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Share this post
Kevin Lind, Biotech Serial CEO, Details…
Share this post
Longboard CEO Details Decision to Sell Publicly-Traded Rare Disease Company